Glucagon-like peptide-1 (GLP-1) analogs have emerged as a compelling therapeutic target for managing metabolic syndromes. These naturally occurring molecules are secreted by the gut in response to meal intake, https://bookmarkassist.com/story20356998/unveiling-the-therapeutic-potential-of-glp-1-peptides